Quinfamide is a synthetic antiparasitic agent belonging to the quinoline class, primarily utilized for the treatment of intestinal amebiasis caused by Entamoeba histolytica. This compound functions by… Read more
Quinfamide is a synthetic antiparasitic agent belonging to the quinoline class, primarily utilized for the treatment of intestinal amebiasis caused by Entamoeba histolytica. This compound functions by inhibiting the synthesis of essential fatty acids that are required for the parasite's survival within the host's gastrointestinal tract. To ensure the safety and efficacy of the active pharmaceutical ingredient, laboratories rely on high-quality reference standards for Quinfamide and its related substances, such as 1-(dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol. These materials are essential for impurity profiling, method validation, and rigorous quality control protocols during pharmaceutical manufacturing. Accessing accurate, well-characterized reference standards, including impurities and, where applicable, stable isotope labelled compounds, supports precise analytical testing and compliance with regulatory requirements throughout the drug development and production lifecycle.